149 related articles for article (PubMed ID: 27542230)
1. PDCD4 is a CSL associated protein with a transcription repressive function in cancer associated fibroblast activation.
Jo SH; Kim DE; Clocchiatti A; Dotto GP
Oncotarget; 2016 Sep; 7(37):58717-58727. PubMed ID: 27542230
[TBL] [Abstract][Full Text] [Related]
2. Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.
Procopio MG; Laszlo C; Al Labban D; Kim DE; Bordignon P; Jo SH; Goruppi S; Menietti E; Ostano P; Ala U; Provero P; Hoetzenecker W; Neel V; Kilarski WW; Swartz MA; Brisken C; Lefort K; Dotto GP
Nat Cell Biol; 2015 Sep; 17(9):1193-204. PubMed ID: 26302407
[TBL] [Abstract][Full Text] [Related]
3. CSL controls telomere maintenance and genome stability in human dermal fibroblasts.
Bottoni G; Katarkar A; Tassone B; Ghosh S; Clocchiatti A; Goruppi S; Bordignon P; Jafari P; Tordini F; Lunardi T; Hoetzenecker W; Neel V; Lingner J; Paolo Dotto G
Nat Commun; 2019 Aug; 10(1):3884. PubMed ID: 31467287
[TBL] [Abstract][Full Text] [Related]
4. Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B.
Al Labban D; Jo SH; Ostano P; Saglietti C; Bongiovanni M; Panizzon R; Dotto GP
J Clin Invest; 2018 Jun; 128(6):2581-2599. PubMed ID: 29757189
[TBL] [Abstract][Full Text] [Related]
5. The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI.
Goruppi S; Procopio MG; Jo S; Clocchiatti A; Neel V; Dotto GP
Cell Rep; 2017 Sep; 20(10):2468-2479. PubMed ID: 28877478
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.
Clocchiatti A; Ghosh S; Procopio MG; Mazzeo L; Bordignon P; Ostano P; Goruppi S; Bottoni G; Katarkar A; Levesque M; Kölblinger P; Dummer R; Neel V; Özdemir BC; Dotto GP
J Clin Invest; 2018 Dec; 128(12):5531-5548. PubMed ID: 30395538
[TBL] [Abstract][Full Text] [Related]
7. Autophagy Controls CSL/RBPJκ Stability through a p62/SQSTM1-Dependent Mechanism.
Goruppi S; Jo SH; Laszlo C; Clocchiatti A; Neel V; Dotto GP
Cell Rep; 2018 Sep; 24(12):3108-3114.e4. PubMed ID: 30231994
[TBL] [Abstract][Full Text] [Related]
8. Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation.
Kim DE; Procopio MG; Ghosh S; Jo SH; Goruppi S; Magliozzi F; Bordignon P; Neel V; Angelino P; Dotto GP
J Exp Med; 2017 Aug; 214(8):2349-2368. PubMed ID: 28684431
[TBL] [Abstract][Full Text] [Related]
9. Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.
Hu B; Castillo E; Harewood L; Ostano P; Reymond A; Dummer R; Raffoul W; Hoetzenecker W; Hofbauer GF; Dotto GP
Cell; 2012 Jun; 149(6):1207-20. PubMed ID: 22682244
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional repression in the Notch pathway: thermodynamic characterization of CSL-MINT (Msx2-interacting nuclear target protein) complexes.
VanderWielen BD; Yuan Z; Friedmann DR; Kovall RA
J Biol Chem; 2011 Apr; 286(17):14892-902. PubMed ID: 21372128
[TBL] [Abstract][Full Text] [Related]
11. A role for stromal autophagy in cancer-associated fibroblast activation.
Goruppi S; Clocchiatti A; Dotto GP
Autophagy; 2019 Apr; 15(4):738-739. PubMed ID: 30653445
[TBL] [Abstract][Full Text] [Related]
12. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.
Jansen AP; Camalier CE; Colburn NH
Cancer Res; 2005 Jul; 65(14):6034-41. PubMed ID: 16024603
[TBL] [Abstract][Full Text] [Related]
13. Negative control of CSL gene transcription by stress/DNA damage response and p53.
Menietti E; Xu X; Ostano P; Joseph JM; Lefort K; Dotto GP
Cell Cycle; 2016 Jul; 15(13):1767-78. PubMed ID: 27163456
[TBL] [Abstract][Full Text] [Related]
14. Down regulation of CSL activity inhibits cell proliferation in prostate and breast cancer cells.
Yong T; Sun A; Henry MD; Meyers S; Davis JN
J Cell Biochem; 2011 Sep; 112(9):2340-51. PubMed ID: 21520243
[TBL] [Abstract][Full Text] [Related]
15. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.
Yang HS; Matthews CP; Clair T; Wang Q; Baker AR; Li CC; Tan TH; Colburn NH
Mol Cell Biol; 2006 Feb; 26(4):1297-306. PubMed ID: 16449643
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of RBP-J-interacting and tubulin-associated (RITA) reveals regions critical for repression of Notch target genes.
Tabaja N; Yuan Z; Oswald F; Kovall RA
J Biol Chem; 2017 Jun; 292(25):10549-10563. PubMed ID: 28487372
[TBL] [Abstract][Full Text] [Related]
17. Loss of CSL Unlocks a Hypoxic Response and Enhanced Tumor Growth Potential in Breast Cancer Cells.
Braune EB; Tsoi YL; Phoon YP; Landor S; Silva Cascales H; Ramsköld D; Deng Q; Lindqvist A; Lian X; Sahlgren C; Jin SB; Lendahl U
Stem Cell Reports; 2016 May; 6(5):643-651. PubMed ID: 27066863
[TBL] [Abstract][Full Text] [Related]
18. Impaired notch signaling promotes de novo squamous cell carcinoma formation.
Proweller A; Tu L; Lepore JJ; Cheng L; Lu MM; Seykora J; Millar SE; Pear WS; Parmacek MS
Cancer Res; 2006 Aug; 66(15):7438-44. PubMed ID: 16885339
[TBL] [Abstract][Full Text] [Related]
19. Programmed cell death 4 protein in esophageal cancer.
Fassan M; Cagol M; Pennelli G; Rizzetto C; Giacomelli L; Battaglia G; Zaninotto G; Ancona E; Ruol A; Rugge M
Oncol Rep; 2010 Jul; 24(1):135-9. PubMed ID: 20514454
[TBL] [Abstract][Full Text] [Related]
20. Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant.
Bordignon P; Bottoni G; Xu X; Popescu AS; Truan Z; Guenova E; Kofler L; Jafari P; Ostano P; Röcken M; Neel V; Dotto GP
Cell Rep; 2019 Aug; 28(9):2358-2372.e6. PubMed ID: 31461652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
